搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
The Pharma Letter
10 小时
Shaping the future: how cultural transformation fuels digital innovation in UK pharma
A century later, that sentiment is as pertinent as ever. Artificial Intelligence (AI) is being incorporated into a myriad of ...
The Pharma Letter
11 小时
OmniaBio opens largest advanced therapy facility
OmniaBio, a subsidiary of Canada's Centre for Commercialization of Regenerative Medicine, has opened a 120,000-square-foot ...
The Pharma Letter
11 小时
LaNova Medicines secures $41 million in series C round
Shanghai-based biopharma LaNova Medicines has raised 3 billion yuan ($41 million) in a series C round led by China ...
The Pharma Letter
11 小时
Merger to create global Treg company
Taiwan-based REGiMMUNE, a biopharma creating immunotherapies through the power of regulatory T cells (Tregs), and ...
The Pharma Letter
13 小时
Coalition of EU groups call for bold and open trade policy
As the European Parliament prepares for the confirmation hearings of the new Commissioners, the Open Trade Coalition is ...
The Pharma Letter
13 小时
Sage slashes further jobs as need to deliver deepens
US biotech company Sage Therapeutics is to slash a third of its remaining jobs - just a year after cutting 40% of its prior workforce.
The Pharma Letter
15 小时
FDA finally approves Vyalev for Parkinson’s disease
After a couple of negative decisions, the US Food and Drug Administration (FDA) has approved Vyalev (foscarbidopa and ...
The Pharma Letter
15 小时
Lexicon pens licensing deal with Viatris for sotagliflozin
Texas, USA-based Lexicon Pharmaceuticals announced that Viatris has obtained an exclusive license from Lexicon to ...
The Pharma Letter
17 小时
Terray Therapeutics closes $120 million financing
California, USA-based biotech Terray Therapeutics, yesterday announced the closing of an oversubscribed Series B funding of ...
The Pharma Letter
17 小时
BenevolentAI founder returns as executive chairman amid leadership overhaul
British AI drug discovery firm BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. His ...
The Pharma Letter
18 小时
BRIEF—UMCG and SHINE receive $11 million grant for cancer study
University Medical Center Groningen and SHINE Europe have secured an €10.5 million ($11 million) grant to boost European ...
The Pharma Letter
1 天
FDA puts partial clinical hold on gotistobart trial
The US Food and Drug Administration (FDA) has placed a partial clinical hold on the two-stage, open-label, randomized Phase ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈